Eloise Thomas

Eloïse Thomas - Maîtresse de Conférences Université Claude Bernard Lyon 1, France LAGEPP : Laboratoire d'Automatique, de Génie des Procédés et de Génie Pharmaceutique - UMR5007 CNRS - France. ISPB : Institut des Sciences Pharmaceutiques et Biologiques - Faculté de Pharmacie de Lyon - France.

Documents

Affiliations actuelles

552962

Identifiants chercheurs

eloise-thomas
ResearcherId : Y-2383-2019
0000-0002-3772-872X
Google Scholar : https://scholar.google.fr/citations?user=jJsU7rUAAAAJ&hl=fr
IdRef : 204202027
ResearcherId : http://www.researcherid.com/rid/Y-2383-2019

Contact

Domaines de recherche

Sciences pharmaceutiques

Publications

	CeO2-based peelable gel for neutralization and skin decontamination toward chemical warfare agents Eloise Thomas , Claire Bordes , Frédéric Chaput , Delphine Arquier , Stéphanie Briançon Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2024, 687, pp.133520. ⟨10.1016/j.colsurfa.2024.133520⟩ Article dans une revue hal-04480655v1
	Combating lead and cadmium exposure with an orally administered chitosan-based chelating polymer Jordyn Ann Howard , Halyna Kuznietsova , Natalia Dziubenko , Axel Aigle , Marco Natuzzi Scientific Reports, 2023, 13 (1), pp.2215. ⟨10.1038/s41598-023-28968-4⟩ Article dans une revue hal-04209149v1
	Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple Myeloma Eloise Thomas , Clélia Mathieu , Patricia Moreno‐gaona , Vincent Mittelheisser , François Lux Advanced Healthcare Materials, 2021, pp.2101565. ⟨10.1002/adhm.202101565⟩ Article dans une revue hal-03469640v1
	Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer Marco Natuzzi , Coralie Grange , Thomas Gréa , Thomas Brichart , Axel Aigle Scientific Reports, 2021, 11 (1), ⟨10.1038/s41598-021-99462-y⟩ Article dans une revue hal-03379081v1
	3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation Irini Skaripa-Koukelli , David Hauton , John Walsby-Tickle , Eloise Thomas , Joshua Owen Cancer & Metabolism, 2021, 9 (1), ⟨10.1186/s40170-021-00273-6⟩ Article dans une revue hal-03379071v1
	Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation Joshua Owen , Eloise Thomas , Jyothi Menon , Michael Gray , Irini Skaripa-Koukelli Journal of Controlled Release, 2020, 319, pp.222-233. ⟨10.1016/j.jconrel.2019.12.045⟩ Article dans une revue hal-02547889v1
	AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine François Lux , Vu Long Tran , Eloise Thomas , Sandrine Dufort , Fabien Rossetti British Journal of Radiology, 2019, 92 (1093), pp.20180365. ⟨10.1259/bjr.20180365⟩ Article dans une revue hal-01935540v1
	Multimodal AGuIX® Nanoparticles: Size Characterization by HF5 and Optimization of the Radiolabeling with Various SPECT/PET/Theranostic Tracers S. Huclier-Markai , E. Ntsiba , Eloise Thomas , C. Alliot , Cs Cutler Int.J.Med.Nano Res., 2019, 6 (1), ⟨10.23937/2378-3664.1410027⟩ Article dans une revue hal-02317372v1
	Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging Vivek Thakare , Vu-Long Tran , Marco Natuzzi , Eloise Thomas , Mathieu Moreau RSC Advances, 2019, 9 (43), pp.24811-24815. ⟨10.1039/C9RA00365G⟩ Article dans une revue hal-02287597v1
	Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy Eloise Thomas , Jyothi Menon , Joshua Owen , Irini Skaripa-Koukelli , Sheena Wallington Theranostics, 2019, 9 (19), pp.5595-5609. ⟨10.7150/thno.34669⟩ Article dans une revue hal-02287691v1
	Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance–Computed Tomography Image Guided Radiation Therapy Alexandre Detappe , Eloise Thomas , Mark W Tibbitt \|\| , Sijumon Kunjachan , Oksana Zavidij Nano Letters, 2017, 17 (3), pp.1733 - 1740. ⟨10.1021/acs.nanolett.6b05055⟩ Article dans une revue hal-01689566v1
	Proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma Magali Toussaint , Sophie Pinel , Florent Auger , Nicolas Durieux , Magalie Thomassin Theranostics, 2017, 7 (2), pp.436-451. ⟨10.7150/thno.17218⟩ Article dans une revue hal-01399256v1
	68 Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy Penelope Bouziotis , Dimitris Stellas , Eloise Thomas , Charles Truillet , Charalampos Tsoukalas Nanomedicine, 2017, 12 (13), pp.1561 - 1574. ⟨10.2217/nnm-2017-0032⟩ Article dans une revue hal-01689547v1
	Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma Eloise Thomas , Ludovic Colombeau , Mickaël Gries , Thibaut Peterlini , Clélia Mathieu International Journal of Nanomedicine, 2017, 12, pp.7075-7088. ⟨10.2147/IJN.S141559⟩ Article dans une revue hal-01643075v1
	Synthesis and Characterization of 89 Zr-Labeled Ultrasmall Nanoparticles Charles Truillet , Eloise Thomas , François Lux , Loc T Huynh , Olivier Tillement Molecular Pharmaceutics, 2016, 13 (7), pp.2596 - 2601. ⟨10.1021/acs.molpharmaceut.6b00264⟩ Article dans une revue hal-01405878v1
	Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection Lucie Sancey , Shady Kotb , Charles Truillet , F. Appaix , Arthur Marais ACS Nano, 2015, 9 (3), pp.2477-2488. ⟨10.1021/acsnano.5b00552⟩ Article dans une revue hal-01207383v1

	Bismuth-Gadolinium Nanoparticles Ross Berbeco , Eloise Thomas , François Lux , Olivier Tillement , Alexandre Detappe United States, Patent n° : WO2018107057A1. 2018 Brevet hal-02548425v1

	Développement d’une seconde génération de nanoparticules AGuIX pour des applications théranostiques en oncologie Eloise Thomas Cancer. Université de Lyon, 2017. Français. ⟨NNT : 2017LYSE1121⟩ Thèse tel-01674228v1

	Ultrasound-Induced Mircobubble Cavitation For Optimisation Of Tumour Uptake Of Liposome-Based Chemo-Radionuclide Therapy Katherine A. Vallis , Eloise Thomas , Jyothi Menon , Joshua Owen , Sheena Wallington Annual Congress of the European Association of Nuclear Medicine, Oct 2019, Barcelona, Spain. pp.1-952, ⟨10.1007/s00259-019-04486-2⟩ Communication dans un congrès hal-02548480v1
	Towards the Synthesis and Delivery of Halogenated MCT1 Substrates Irini Skaripa-Koukelli , John Walsby-Tickle , Joshua Owen , Eloise Thomas , James Mccullagh Oncological Drug Delivery Conference, Sep 2019, Oxford, United Kingdom Communication dans un congrès hal-03989472v1
	Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma Noémie Thomas , Mickaël Gries , Ludovic Colombeau , Eloise Thomas , Cédric Boura International Conference on Porphyrins and Phthalocyanines, ICCP-10, Jul 2018, Munich, Germany Communication dans un congrès hal-01845326v1
	AGuIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors Ludovic Colombeau , Eloise Thomas , Noémie Thomas , Muriel Barberi-Heyob , François Lux 17th Congress of the European Society for Photobiology, Sep 2017, Pise, Italy Communication dans un congrès hal-02550754v1
	Functionalization of AGuIX nanoparticles for improved radiotherapy Eloise Thomas , Alexandre Detappe , Ross Berbeco , François Lux , Olivier Tillement Nano-Hybrides n°14, May 2017, Bastia, France Communication dans un congrès hal-02548188v1
	Vascular targeting for the treatment of glioblastoma by PDT Céline Frochot , Ludovic Colombeau , Eloise Thomas , Régis Vanderesse , Magali Toussaint 16th International Photodynamic Association World Congress, IPA 2017, Jun 2017, Coimbra, Portugal Communication dans un congrès hal-03243053v1
	Gadolinium-based nanoparticles for the treatment of glioblastoma by MRI-guided photodynamic therapy Eloise Thomas , Magali Toussaint , Ludovic Colombeau , Mickaël Gries , Thibaut Peterlini World Molecular Imaging Congress, WMIC 2017, Sep 2017, Philadelphia, United States Communication dans un congrès hal-02548177v1
	Use of MR Imaging and proton MR Spectroscopy imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma Magali Toussaint , Florent Auger , Sophie Pinel , Magalie Thomassin , Eloise Thomas Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France Communication dans un congrès hal-01407476v1
	Interstitial photodynamic therapy for glioblastoma: interest of MRI monitoring to predict iPDT effects. Magali Toussaint , Florent Auger , Sophie Pinel , Nicolas Durieux , Magalie Thomassin 13e Colloque Nano-hybrides, ILM, Lyon 1, May 2016, Porquerolles, France Communication dans un congrès hal-01312929v1
	Development of new synthesis protocol and advanced characterization of AGuIX Nanoparticle Vu Long Tran , Arthur Marais , Eloise Thomas , Cédric Louis , François Lux ITN-ARGENT, Nov 2015, Obergurgl, Austria Communication dans un congrès hal-03989480v1
	Ultrasmall nanoparticles functionalization for PET and SPECT imaging Eloise Thomas , François Lux , Olivier Tillement Nano-Hybrides n°12, May 2015, Bastia, France Communication dans un congrès hal-02548199v1
	AGuIX nanoparticles for PET/MRI François Lux , Lucie Sancey , Eloise Thomas , Olivier Tillement France Life Imaging, Dec 2014, Lyon, France Communication dans un congrès hal-02548210v1

	CeO2-based peelable gel for neutralization and skin decontamination toward chemical warefare agent simulants Eloise Thomas , Delphine Arquier , C. Barratier , Claire Bordes , Fréderic Chaput Formula XI, Jul 2023, Lille, France Poster de conférence hal-04462743v1
	Monoclonal antibodies decorated nanoparticles for the treatment of triple negative breast cancer Silvia Breusa , Jean‐guy Delcros , Eloise Thomas , Serena Zilio , Diana Marcela Hernandez Palomino SFNano Annual Meeting, Dec 2022, Strasbourg, France Poster de conférence hal-03989500v1
	Ultrasound And Microbubbles Enhance The Delivery Of A Liposomal Formulation For Targeted Chemo-Radionuclide Therapy Eloise Thomas , Jyothi Menon , Joshua Owen , Sheena Wallington , Michael Gray British Nuclear Medicine Society Spring Meeting, Apr 2019, Oxford, United Kingdom Poster de conférence hal-02548236v1
	Ultrasound-Mediated Cavitation To Enhance The Delivery Of Liposomal Formulations For Targeted Radionuclide Therapy Eloise Thomas , Jyothi Menon , Joshua Owen , Sheena Wallington , Michael Gray Controlled Release Society Annual Meeting, Jul 2019, Valencia, Spain Poster de conférence hal-02548225v1
	Indium-111 afterloading of preformed EGF containing liposomes for molecularly targeted radionuclide delivery via ultrasound induced cavitation. Joshua Owen , Jyothi Menon , Eloise Thomas , Irini Skaripa-Koukelli , Martin Gill Annual Congress of the European Association of Nuclear Medicine, Oct 2018, Düsseldorf, Germany. European Journal of Nuclear Medicine and Molecular Imaging, 45 (S1), pp.1-844, 2019, ⟨10.1007/s00259-018-4148-3⟩ Poster de conférence hal-02548464v1
	Targeted and combined chemo-radionucleide therapy for the treatment of breast cancers Eloise Thomas , Jyothi Menon , Joshua Owen , Irini Skaripa-Koukelli , Robert Carlisle CRUK Symposium, Jun 2018, Oxford, United Kingdom Poster de conférence hal-02548247v1
	Silica-Based Bismuth-Gadolinium Nanoparticles for MRI and CT Image-Guided Radiation Therapy Alexandre Detappe , Eloise Thomas , M. Tibbitt , S. Kunjachan , O. Zavidij ASTRO annual meeting, Sep 2017, San Diego, United States Poster de conférence hal-03989491v1
	AGUIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors Ludovic Colombeau , Eloise Thomas , Thibaut Peterlini , Mickaël Gries , Noémie Thomas Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. , 17, pp.A71, 2017, ⟨10.1016/j.pdpdt.2017.01.161⟩ Poster de conférence hal-01408883v1
	PET and MR imaging with 64Cu/68Ga-labeled AGuIX ultra-small nanoparticles in tumor-bearing mice Marie-Caline Abadjian , Eloise Thomas , Joseph Latoche , Lesley Foley , Kathryn Day SNMMI Annual Meeting, Jun 2016, San Diego, United States. 57 (Supplement2), pp.1181, 2016 Poster de conférence hal-02548345v1
	Radiolabeling for long term biodistribution of ultrasmall nanoparticles designed for radiotherapy guided by MRI Eloise Thomas , Charles Truillet , Franck Denat , François Lux , Frederic Boschetti World Molecular Imaging Congress, Sep 2016, New-York, United States Poster de conférence hal-02548258v1
	Ultrasmall gadolinium-based nanoparticles designed for photodynamic therapy (PDT) guided by MRI E Thomas , M Toussaint , Ludovic Colombeau , Céline Frochot , Régis Vanderesse Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. , Photodiagnosis and Photodynamic Therapy, 17, pp.A60, 2017, ⟨10.1016/j.pdpdt.2017.01.136⟩ Poster de conférence hal-01498485v1
	Functionalization of ultrasmall nanoparticles for theranosctic applications Eloise Thomas , Frederic Boschetti , Franck Denat , François Lux , Olivier Tillement COST TD1004 Action Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging-Guided Drug Delivery, Oct 2015, Belgrade, Serbia Poster de conférence hal-02548269v1
	AGuIX modifications for active tumor targeting and radiolabelling Eloise Thomas , Charles Truillet , Marie Plissonneau , Frederic Boschetti , Franck Denat COST TD1004 Action Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging-Guided Drug Delivery, Oct 2014, Istanbul, Turkey Poster de conférence hal-02548293v1

Eloise Thomas

Présentation

Domaines de recherche

Publications

CeO2-based peelable gel for neutralization and skin decontamination toward chemical warfare agents

Combating lead and cadmium exposure with an orally administered chitosan-based chelating polymer

Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple Myeloma

Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation

Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation

AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine

Multimodal AGuIX® Nanoparticles: Size Characterization by HF5 and Optimization of the Radiolabeling with Various SPECT/PET/Theranostic Tracers

Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging

Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy

Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance–Computed Tomography Image Guided Radiation Therapy

Proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma

68 Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy

Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma

Synthesis and Characterization of 89 Zr-Labeled Ultrasmall Nanoparticles

Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection

Bismuth-Gadolinium Nanoparticles

Développement d’une seconde génération de nanoparticules AGuIX pour des applications théranostiques en oncologie

Ultrasound-Induced Mircobubble Cavitation For Optimisation Of Tumour Uptake Of Liposome-Based Chemo-Radionuclide Therapy

Towards the Synthesis and Delivery of Halogenated MCT1 Substrates

Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma

AGuIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors

Functionalization of AGuIX nanoparticles for improved radiotherapy

Vascular targeting for the treatment of glioblastoma by PDT

Gadolinium-based nanoparticles for the treatment of glioblastoma by MRI-guided photodynamic therapy

Use of MR Imaging and proton MR Spectroscopy imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma

Interstitial photodynamic therapy for glioblastoma: interest of MRI monitoring to predict iPDT effects.

Development of new synthesis protocol and advanced characterization of AGuIX Nanoparticle

Ultrasmall nanoparticles functionalization for PET and SPECT imaging

AGuIX nanoparticles for PET/MRI

CeO2-based peelable gel for neutralization and skin decontamination toward chemical warefare agent simulants

Monoclonal antibodies decorated nanoparticles for the treatment of triple negative breast cancer

Ultrasound And Microbubbles Enhance The Delivery Of A Liposomal Formulation For Targeted Chemo-Radionuclide Therapy

Ultrasound-Mediated Cavitation To Enhance The Delivery Of Liposomal Formulations For Targeted Radionuclide Therapy

Indium-111 afterloading of preformed EGF containing liposomes for molecularly targeted radionuclide delivery via ultrasound induced cavitation.

Targeted and combined chemo-radionucleide therapy for the treatment of breast cancers

Silica-Based Bismuth-Gadolinium Nanoparticles for MRI and CT Image-Guided Radiation Therapy

AGUIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors

PET and MR imaging with 64Cu/68Ga-labeled AGuIX ultra-small nanoparticles in tumor-bearing mice

Radiolabeling for long term biodistribution of ultrasmall nanoparticles designed for radiotherapy guided by MRI

Ultrasmall gadolinium-based nanoparticles designed for photodynamic therapy (PDT) guided by MRI

Functionalization of ultrasmall nanoparticles for theranosctic applications

AGuIX modifications for active tumor targeting and radiolabelling